Sex differences among subcutaneous defibrillator (S-ICD) recipients: a propensity-matched, multicenter, international analysis from the i-SUSI project.

S-ICD appropriate shocks gender differences sex differences sudden cardiac death

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
02 May 2024
Historique:
received: 28 02 2024
revised: 27 03 2024
accepted: 02 04 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 2 5 2024
Statut: aheadofprint

Résumé

Women have been historically underrepresented in implantable cardioverter defibrillator (ICD) trials. No data on sex differences regarding subcutaneous-ICDs (S-ICD) carriers have been described. Aim of our study was to investigate sex-related differences among unselected S-ICD recipients. Consecutive patients enrolled in the multicenter, international i-SUSI registry were analyzed. Comparisons between sexes were performed using a 1:1 propensity matching adjusted analysis for age, body mass index (BMI), left ventricular function and substrate. The primary outcome was the rate of appropriate shocks during follow-up. Inappropriate shocks and other device-related complications were deemed secondary outcomes. A total of 1698 patients were extracted from the iSUSI registry; 399 (23.5%) were females. After propensity matching, two cohorts of 374 patients presenting similar baseline characteristics were analyzed. Despite similar periprocedural characteristics and a matched BMI, women resulted at lower risk of conversion failure as per PRAETORIAN score (73.4% vs 81.3%, p = 0.049). Over a median follow-up time of 26.5 [12.7-42.5] months, appropriate shocks were more common in the male cohort (rate/year 3.4%vs1.7%; log-rank p = 0.049), while no significant differences in device-related complications (rate/year: 6.3% vs 5.8%; log-rank p = 0.595) and inappropriate shocks (rate/year: 4.3%vs3.1%; log-rank p = 0.375) were observed. After controlling for confounders, sex remained significantly associated with the primary outcome (aHR 1.648; CI 0.999-2.655, p = 0.048), while not resulting predictor of inappropriate shocks and device-related complications. In a propensity-matched cohort of S-ICD recipients, women are less likely to experience appropriate ICD therapy, while not showing higher risk of device related-complications.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Women have been historically underrepresented in implantable cardioverter defibrillator (ICD) trials. No data on sex differences regarding subcutaneous-ICDs (S-ICD) carriers have been described. Aim of our study was to investigate sex-related differences among unselected S-ICD recipients.
METHODS METHODS
Consecutive patients enrolled in the multicenter, international i-SUSI registry were analyzed. Comparisons between sexes were performed using a 1:1 propensity matching adjusted analysis for age, body mass index (BMI), left ventricular function and substrate. The primary outcome was the rate of appropriate shocks during follow-up. Inappropriate shocks and other device-related complications were deemed secondary outcomes.
RESULTS RESULTS
A total of 1698 patients were extracted from the iSUSI registry; 399 (23.5%) were females. After propensity matching, two cohorts of 374 patients presenting similar baseline characteristics were analyzed. Despite similar periprocedural characteristics and a matched BMI, women resulted at lower risk of conversion failure as per PRAETORIAN score (73.4% vs 81.3%, p = 0.049). Over a median follow-up time of 26.5 [12.7-42.5] months, appropriate shocks were more common in the male cohort (rate/year 3.4%vs1.7%; log-rank p = 0.049), while no significant differences in device-related complications (rate/year: 6.3% vs 5.8%; log-rank p = 0.595) and inappropriate shocks (rate/year: 4.3%vs3.1%; log-rank p = 0.375) were observed. After controlling for confounders, sex remained significantly associated with the primary outcome (aHR 1.648; CI 0.999-2.655, p = 0.048), while not resulting predictor of inappropriate shocks and device-related complications.
CONCLUSION CONCLUSIONS
In a propensity-matched cohort of S-ICD recipients, women are less likely to experience appropriate ICD therapy, while not showing higher risk of device related-complications.

Identifiants

pubmed: 38696701
pii: 7663397
doi: 10.1093/europace/euae115
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

A Gasperetti (A)
R Arosio (R)
M Viecca (M)
G B Forleo (GB)
M Schiavone (M)
F Tundo (F)
M Moltrasio (M)
C Tondo (C)
M Ziacchi (M)
I Diemberger (I)
A Angeletti (A)
M Biffi (M)
N Fierro (N)
S Gulletta (S)
P Della Bella (PD)
G Mitacchione (G)
A Curnis (A)
P Compagnucci (P)
M Casella (M)
A Dello Russo (AD)
L Santini (L)
C Pignalberi (C)
M Magnocavallo (M)
A Piro (A)
C Lavalle (C)
F Picarelli (F)
D Ricciardi (D)
E Bressi (E)
L Calò (L)
E Montemerlo (E)
G Rovaris (G)
S De Bonis (S)
A Bisignani (A)
G Bisignani (G)
G Russo (G)
E Pisanò (E)
P Palmisano (P)
F Guarracini (F)
F Vitali (F)
M Bertini (M)
J Vogler (J)
T Fink (T)
R Tilz (R)
F Fastenrath (F)
J Kuschyk (J)
L Kaiser (L)
S Hakmi (S)
M Laredo (M)
X Waintraub (X)
E Gandjbakhch (E)
N Badenco (N)
A Breitenstein (A)
A M Saguner (AM)
M Martine (M)
S Seidl (S)
X Zhang (X)
L Di Biase (L)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Marco Schiavone (M)

Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan-Italy.
Department of Systems Medicine, University of Rome Tor Vergata, Rome-Italy.

Alessio Gasperetti (A)

Department of Cardiology, Johns Hopkins University, Baltimore-USA.

Julia Vogler (J)

Department of Rhythmology, University Heart Center Lübeck, Lubeck-Germany.

Paolo Compagnucci (P)

Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti", Ancona-Italy.

Mikael Laredo (M)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière and Sorbonne Université, Paris-France.

Alexander Breitenstein (A)

Cardiology Clinic, University Hospital Zurich, Zurich-Switzerland.

Simone Gulletta (S)

Arrhythmology and Electrophysiology Unit, San Raffaele Hospital, IRCCS, Milan-Italy.

Martin Martinek (M)

Ordensklinikum Linz Elisabethinen Internal Medicine 2 with Cardiology, Angiology, and Intensive Care Medicine, Linz-Austria.

Lukas Kaiser (L)

Department of Cardiology and Critical Care Medicine, St. George Klinik Asklepios, Hamburg-Germany.

Fabrizio Tundo (F)

Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan-Italy.

Pietro Palmisano (P)

Cardiology Unit, "Card. G. Panico" Hospital, Tricase-Italy.

Giovanni Rovaris (G)

Cardiology Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza-Italy.

Antonio Curnis (A)

Cardiology Unit, Spedali Civili Brescia, Brescia-Italy.

Jürgen Kuschyk (J)

Cardiology Unit, University Medical Centre Mannheim, Manheim-Germany.

Mauro Biffi (M)

Cardiology Unit, IRCCS, Department of Experimental, Diagnostic and Specialty Medicine, Sant'Orsola Hospital, University of Bologna-Italy.

Roland Tilz (R)

Department of Rhythmology, University Heart Center Lübeck, Lubeck-Germany.

Luigi Di Biase (L)

Cardiac Arrhythmia Center, Division of Cardiology at Montefiore-Einstein Center, Bronx, New York-USA.

Claudio Tondo (C)

Department of Clinical Electrophysiology & Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan-Italy.
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan-Italy.

Giovanni B Forleo (GB)

Cardiology Unit, Luigi Sacco University Hospital, Milan-Italy.

Classifications MeSH